Other authors subsequently reported higher CPT1C expression (mRNA or protein levels) in other types of tumors, e.g., papillary thyroid carcinomas [24] and hepatocellular carcinomas [21] than in normal tissues. This evidence concerns the gene CPT1C and differentiated thyroid carcinoma.